You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Macedonia

Sep 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Macedonia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Macedonia, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Macedonia for free:

The Consumer Health in Macedonia market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Macedonia?
  • What are the major brands in Macedonia?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Strong growth thanks to growth in self-medication

Consumer health saw strong growth during the review period, as consumers increasingly took charge of their own health. There was a growing confidence in self-medication, with this linked to stronger advertising for OTC remedies and rising faith in the advice offered by pharmacists. This trend was also encouraged by the lengthy waiting times generally associated with visits to the doctor, with many busy consumers preferring to save time by self-medicating.

Economic downturn dampens growth

Growth notably slowed in the last years of the review period, with this chiefly due to the lingering impact of the economic downturn at the end of the review period. High inflation and rising unemployment increased many consumers’ economic uncertainty, with this hindering sales growth in many areas. Consumers increasingly purchased consumer health only if in need, with this hindering sales for products that contribute to health rather than addressing symptoms, such as vitamins and dietary supplements and sports nutrition.

Strong domestic leader further gains share

Alkaloid was a strong leader in consumer health in 2010 and further gained share over the previous year. The company benefited from strong marketing investment towards the end of the review period, targeting both consumers and pharmacists. The company increasingly targeted pharmacists with its marketing, with this resulting in more frequent recommendations in chemists/pharmacies. The remaining top five players were however international, including Krka, Bayer, Bristol-Myers Squibb and Lek.

Chemists/pharmacies continue to dominate due to distribution controls

Most OTC products can only be sold via chemists/pharmacies, with this channel consequently having a strong dominance in consumer health. This is for example the only channel that offers adult mouth care, analgesics, calming and sleeping products and ear care and it dominates all product areas other than sports nutrition and vitamins and dietary supplements. Even when buying unregulated products such as wound care, consumers are more likely to visit chemists/pharmacies due to this channel’s wide range of products across consumer health.

Slower growth ahead for forecast period

Consumer health is expected to see slower growth during the forecast period in comparison to that seen during the review period. There was a strong surge in self-medication during the review period, which resulted in strong growth rates. With a higher sales base and rising maturity, these growth rates are unlikely to be matched during the forecast period. Growth is expected to remain good, however, with this underpinned by a further shift towards self-medication and strong advertising by leading players such as Alkaloid.

Table of Contents

Table of Contents

Consumer Health in Macedonia - Industry Overview

EXECUTIVE SUMMARY

Strong growth thanks to growth in self-medication

Economic downturn dampens growth

Strong domestic leader further gains share

Chemists/pharmacies continue to dominate due to distribution controls

Slower growth ahead for forecast period

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares 2006-2010
  • Table 6 Consumer Health Brand Shares 2007-2010
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and preventative medicine

Switches

DEFINITIONS

  • Summary 1 Research Sources

Consumer Health in Macedonia - Company Profiles

Alkaloid AD Skopje in Consumer Health (Macedonia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 4 Alkaloid AD Skopje: Production Statistics 2009

COMPETITIVE POSITIONING

  • Summary 5 Alkaloid AD Skopje: Competitive Position 2010

Galafarm dooel Skopje in Consumer Health (Macedonia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

Replekpharm AD in Consumer Health (Macedonia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 10 Replekpharm AD: Production Statistics 2009

COMPETITIVE POSITIONING

  • Summary 11 Replekpharm AD: Competitive Position 2010

Adult Mouth Care in Macedonia - Category Analysis

HEADLINES

TRENDS

  • There was a growing consumer trend towards self-medicating mouth problems towards the end of the review period, with this linked to number of factors. Firstly, there was a growing confidence in self-medication in general, with consumers becoming more confident in pharmacists’ recommendations. In addition, economic uncertainty towards the end of the review period resulted in many consumers becoming more reluctant to visit dentists, with dental treatment often being expensive. Instead, many consumers opted to treat teeth and gum pain with adult mouth care.

SWITCHES

COMPETITIVE LANDSCAPE

  • Apimell was a clear leader in adult mouth care in 2010 and accounted for a steady 25% value share. The company’s range is based on Macedonian propolis and herbs and offers an anaesthetic, anti-bacterial and anti-inflammatory effect. The company benefits from offering products that are viewed as safe and effective. The company also benefits from wide distribution and frequent pharmacist recommendations.

PROSPECTS

  • Adult mouth care is expected to continue to benefit from a growing consumer confidence in self-medication during the forecast period. Many consumers will for example seek to ward off dental problems by using Apimell’s range, which is believed to be highly anti-bacterial. Ongoing economic uncertainty for many will also result in many postponing dental visits, attempting to cope with tooth and gum pain by using adult mouth care.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2005-2010
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 13 Adult Mouth Care Company Shares 2006-2010
  • Table 14 Adult Mouth Care Brand Shares 2007-2010
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Macedonia - Category Analysis

HEADLINES

TRENDS

  • Analgesics benefited from growing consumer confidence in self-medication towards the end of the review period. This confidence was partly due to general trends. Stronger media consumer health coverage and widening internet access offered consumers more confidence in assessing their own symptoms while a cumbersome medical system encouraged consumers to seek advice from pharmacists rather than doctors.

SWITCHES

COMPETITIVE LANDSCAPE

  • Alkaloid was the dominant player in analgesics in 2010, accounting for 58% value share in overall analgesics and 61% share in topical analgesics/anaesthetic. This player benefits from its long presence in the country and from strong consumer trust. The company has extensive distribution and offers the strong Caffetin and Analgin brands, which accounted for 37% and 17% value share respectively in systemic analgesics in 2010.

PROSPECTS

  • Analgesics is expected to continue to see steady growth during the forecast period. Growth will continue to be underpinned by strong advertising for the leading brands, particularly Alkaloid’s Caffetin and Analgin brands. Growth will also be supported by ongoing growth in consumers’ confidence in their ability to self-medicate and by the country’s expected economic growth during the forecast period.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2005-2010
  • Table 18 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 19 Analgesics Company Shares 2006-2010
  • Table 20 Analgesics Brand Shares 2007-2010
  • Table 21 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 22 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Macedonia - Category Analysis

HEADLINES

TRENDS

  • Calming and sleeping products benefited greatly from stricter controls on under-the-counter sales of Rx calming and sleeping products during the review period. The government worked to prevent such sales, due to the abuse, misuse and potential health problems associated with Rx medication. Consequently, many consumers were forced to switch to OTC calming and sleeping products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Lek was a clear leader in 2010, accounting for 45% value share. The company benefits from strong consumer awareness of its Persen brand and also from offering two strengths of this brand. Unsurprisingly, its stronger variant Persen Forte proved particularly popular with those transitioning from Rx medicines towards the end of the review period as a result of stricter controls on under-the-counter sales. Consequently, Lek gained an impressive five percentage points in value share in 2010 over the previous year and seven percentage points from 2007.

PROSPECTS

  • Rx medicines will continue to pose the most significant competition to OTC calming and sleeping products during the forecast period. While the government sought to clamp down on under-the-counter sales of Rx medicines at the end of the review period, some chemists/pharmacies continued to sell these products without requesting prescriptions. Consequently, many consumers are likely to continue to buy Rx medicines such as bromazepam, diazepam and lorazepam, regarding these as more effective in comparison to OTC calming and sleeping products.

CATEGORY DATA

  • Table 23 Sales of Calming and Sleeping: Value 2005-2010
  • Table 24 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 25 Calming and Sleeping Company Shares 2006-2010
  • Table 26 Calming and Sleeping Brand Shares 2007-2010
  • Table 27 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 28 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Macedonia - Category Analysis

HEADLINES

TRENDS

  • Cough, cold and allergy (hay fever) remedies was a growing fear of flu at the end of the review period. This was chiefly due to the swine flu epidemic of 2009, which hit Macedonia hard. By March 2011, an estimated 25,000 people had been infected by swine flu, with six deaths in 2009 and a further 21 deaths in the 2010/2011 winter season. Coverage of swine flu meanwhile resulted in a growing consumer focus on coughs and colds, with many proving more prompt in treating symptoms as a result.

SWITCHES

COMPETITIVE LANDSCAPE

  • Krka Farma was the leading player in cough, cold and allergy (hay fever) remedies in 2010, accounting for 23% value share. The company offers the strong brands Herbion in cough remedies and child-specific cough cold remedies and Septolete in cough remedies and pharyngeal preparations. The company however lost over a percentage point in value share in the year, with this due to stronger competition from combination products.

PROSPECTS

  • Macedonia’s problems with swine flu continued into 2011, with six people notably dying of the disease in one week in March 2011. Consequently, the Macedonian media and population will continue to be strongly focused on the dangers of flu at the start of the forecast period. Consumers will become more likely to treat coughs and colds at the first sing of symptoms, thus hoping to avoid weakening their immune system and developing full-blown flu.

CATEGORY DATA

  • Table 29 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 31 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2006-2010
  • Table 32 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2007-2010
  • Table 33 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 34 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Macedonia - Category Analysis

HEADLINES

TRENDS

  • Consumers showed growing confidence in diarrhoeal remedies and laxatives towards the end of the review period, with this mainly due to strong advertising for the leading brands. Lek’s Linex and Krka’s Novolax benefited from TV advertising within diarrhoeal remedies and laxatives respectively, driving sales growth in these areas. This gave consumers the confidence to self-medicate in response to the first sign of symptoms, rather than suffering symptoms or seeking a doctor’s advice.

SWITCHES

COMPETITIVE LANDSCAPE

  • Krka Farma was the leading player in digestive remedies in 2010 with a value share of 27%, followed by Lek with 23% share. These players benefit from strong brands, with Krka offering Novolax in laxatives and Rutacid in antacids and Lek offering Linex in diarrhoeal remedies. These brands benefit from strong advertising support, with effective TV advertising in 2010 resulting in both players gaining around a percentage point in value share over the previous year.

PROSPECTS

  • There is a growing health and wellness trend in Macedonia, with this likely to hinder sales of digestive remedies during the forecast period. Consumers are becoming increasingly aware of the benefits of a healthy diet and also more aware of the benefits of pro/pre biotic products, particularly yoghurt. Consequently, a growing focus on eating a healthy diet could well hinder sales growth for digestive remedies during the forecast period.

CATEGORY DATA

  • Table 35 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 36 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 37 Digestive Remedies Company Shares 2006-2010
  • Table 38 Digestive Remedies Brand Shares 2007-2010
  • Table 39 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Macedonia - Category Analysis

HEADLINES

TRENDS

  • Sales of ear care benefited from widening distribution at the end of the review period, with this in turn increasing availability and consumer awareness. The main instigator behind the push for wider distribution was Gradska Apteka, which dramatically expanded the reach of NaCl in the last two years of the review period as its chain of chemists/pharmacies expanded. This domestic brand is also priced at an affordable level, which encouraged many consumers to try ear care for the first time.

SWITCHES

COMPETITIVE LANDSCAPE

  • Gradska Apteka was the clear leader in ear care in 2010, with the company accounting for a strong 34% value share. The company benefited from expanding distribution for its affordably-priced NaCl generic across its own chain of chemists/pharmacies, with this chain also expanding towards the end of the review period. As a result, Gradska Apteka further gained 10 percentage points in value share in 2010 over the previous year, making it the fastest-growing player in ear care.

PROSPECTS

  • Ear care is expected to benefit from widening consumer awareness during the forecast period. Gradska Apteka is expected to continue to gain share for its NaCl generic, benefiting from wide distribution and an affordable price. The brand is unlikely to see advertising support but may well benefit from word-of-mouth recommendations at the start of the forecast period, due to its low price and reasonable quality.

CATEGORY DATA

  • Table 41 Sales of Ear Care: Value 2005-2010
  • Table 42 Sales of Ear Care: % Value Growth 2005-2010
  • Table 43 Ear Care Company Shares 2006-2010
  • Table 44 Ear Care Brand Shares 2007-2010
  • Table 45 Forecast Sales of Ear Care: Value 2010-2015
  • Table 46 Forecast Sales of Ear Care: % Value Growth 2010-2015

Eye Care in Macedonia - Category Analysis

HEADLINES

TRENDS

  • Growth began to slow once more in 2010, following a two year period of double-digit growth. In 2008 and 2009 current value sales rose by 10% and 12% respectively, with this growth linked to widening retail availability and hence rising awareness. Chemists/pharmacies began to offer a wider range of eye care, with this resulting in strong sales. In 2010, however, growth began to slow due to a higher sales base and greater maturity. Consequently, current value sales grew by less than 5% in the year, in comparison to a review period current value CAGR of over 6%.

SWITCHES

COMPETITIVE LANDSCAPE

  • Alkaloid was the dominant player in eye care at the end of the review period, accounting for 76% value share. The company’s Proculin and Vizine brands enjoy the widest distribution in eye care and are offered at affordable prices. These products consequently prove widely popular.

PROSPECTS

  • Eye care is expected to continue to benefit from rising computer and TV usage during the forecast period. These trends are expected to become more pronounced as Macedonia’s economy continues to grow. Economic growth is likely to result in a growing number of office workers in the country and growing household penetration for internet enabled computers and satellite TV. Consequently, consumers are expected to suffer from dry and tired eyes more frequently.

CATEGORY DATA

  • Table 47 Sales of Eye Care by Category: Value 2005-2010
  • Table 48 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 49 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 50 Eye Care Company Shares 2006-2010
  • Table 51 Eye Care Brand Shares 2007-2010
  • Table 52 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 53 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Macedonia - Category Analysis

HEADLINES

TRENDS

  • There was a shift away from medicinal teas at the end of the review period, with this linked to rising concern about the level of active ingredients in these products. Increasingly, consumers instead sought out herbal/traditional products that offered a standardised dosage of active ingredients. Consumers generally began to regard capsules and tablets as more effective than medicinal teas, as well as viewing these formats as more convenient, with this trend linked to negative media coverage of the efficacy of some medicinal teas. As a result, while all other product areas in herbal/traditional products saw good growth in 2010, medicinal teas declined by 19% in current value terms.

PROSPECTS

  • There is expected to be a growing interest in herbal/traditional products during the forecast period. Consumers are becoming increasingly interested in natural remedies, while the range of herbal/traditional products is expected to further widen during the forecast period. Given Macedonia’s strong tradition in herbal medicine, this is likely to be a key area of development for domestic players such as Alkaloid and Galafarm during the forecast period.

CATEGORY DATA

  • Table 54 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 55 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 56 Herbal/Traditional Products Company Shares 2006-2010
  • Table 57 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 58 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 59 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Macedonia - Category Analysis

HEADLINES

TRENDS

  • Self-medication not only gained popularity as a means of avoiding time-consuming doctor’s visits during the review period. There was also a growing trend towards self-medicating for embarrassing ailments such as vaginal fungal infections and lice, rather than seeking doctor’s advice. This trend was particularly encouraged by strong advertising for vaginal antifungals brands Betadine and Kantarion, from Alkaloid and Fitopharm respectively.

SWITCHES

COMPETITIVE LANDSCAPE

  • Fitopharm was the clear leader in medicated skin care in 2010, accounting for a value share of 18%. The company benefits from offering a range of brands, including Kantarion in vaginal antifungals, Losion and Klimicin in acne treatments and Herpesan in cold sore treatments. The company supported Kantarion, Losion and Klimicin with strong advertising towards the end of the review period. Effective promotional support thus resulted in Fitopharm seeing the strongest growth in value share in 2010 over the previous year, with the company gaining over two percentage points.

PROSPECTS

  • Sales of medicated skin care are expected to be constrained by strong competition from beauty and personal care during the forecast period. Acne treatments and medicated shampoos are particularly likely to suffer, with cosmetic brands benefiting from stronger branding and marketing support. Cosmetic brands also typically offer lower prices and are thus likely to attract a wider consumer base in comparison to medicated skin care.

CATEGORY DATA

  • Table 60 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 61 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 62 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 63 Medicated Skin Care Brand Shares 2007-2010
  • Table 64 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 65 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

Sports Nutrition in Macedonia - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition has a limited consumer base in Macedonia, with most consumers having little awareness of these products. Sales are largely limited to young male professional or semi-professional athletes and body builders. Most consumers remain wary of sports nutrition, associating these products with steroids. This lack of consumer awareness and limited interest continued to constrain sales for sports nutrition at the end of the review period.

COMPETITIVE LANDSCAPE

  • Sales of sports nutrition remained highly fragmented at the end of the review period, with no clear leader. Sales are dominated by imports, with these accounting for an estimated 95% of value sales in 2010. The player with the most consistent distribution presence at the end of the review period was Twinlab, with Belgium Body Service also having a strong presence for its Optimum Nutrition 100% Whey.

PROSPECTS

  • Sales are likely to continue to be limited by a number of factors during the forecast period. Firstly, the number of consumers taking part in regular sports or exercise is small, with the majority being women taking part in aerobic or flexibility exercise, such as cycling and yoga. These consumers typically have little awareness of or interest in sports nutrition, regarding it as the preserve of male bodybuilders. Consequently, sales of sports nutrition will continue to be limited mainly to professional and semi-professional male athletes and bodybuilders during the forecast period. The majority of consumers will continue to have little awareness of sports nutrition and to associate these products with illegal steroids.

CATEGORY DATA

  • Table 66 Sales of Sports Nutrition: Value 2005-2010
  • Table 67 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 68 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 69 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 70 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Macedonia - Category Analysis

HEADLINES

TRENDS

  • Vitamins and dietary supplements benefited strongly from the health and wellness trend in Macedonia during the review period. Consumers became increasingly aware of nutrition and of the benefits offered by vitamins and dietary supplements. Strong advertising for vitamins and dietary supplements brands such as Wyeth’s Centrum and Galenika’s Oligovit also resulted in a growing consumer interest in this product area.

VITAMINS

DIETARY SUPPLEMENTS

PROSPECTS

  • Herbal vitamins and dietary supplements is expected to see the strongest growth during the forecast period, with a growing interest in the benefits of a handful of specific products. Echinacea, ginkgo biloba and St John’s wort are expected to see the strongest growth rates, with a constant value CAGR of 5% each during the forecast period. Echinacea is expected to benefit from widening awareness of its ability to boost the immune system, while St John’s Wort will become increasingly popular as a treatment for depression. Ginkgo biloba is meanwhile likely to benefit from its role as a memory booster and in general brain health, thus appealing to ageing consumers. These herbs are expected to see strong media coverage and will thus attract a widening range of consumers during the forecast period.

CATEGORY DATA

  • Table 71 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 72 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 73 Dietary Supplements by Positioning 2006-2010
  • Table 74 Vitamins and Dietary Supplements Company Shares 2006-2010
  • Table 75 Vitamins and Dietary Supplements Brand Shares 2007-2010
  • Table 76 Vitamins Brand Shares 2007-2010
  • Table 77 Dietary Supplements Brand Shares 2007-2010
  • Table 78 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 79 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Macedonia - Category Analysis

HEADLINES

TRENDS

  • There was growing awareness of the dangers of excess weight during the review period, with consumers becoming more aware of the links between excess weight and problems such as diabetes and heart health. This trend was most pronounced among urban consumers below the age of 40-years-old at the end of the review period. However, many consumers continue to be unaware of or uninterested in such links. Many older consumers associate excess weight with wealth, particularly among men.

COMPETITIVE LANDSCAPE

  • Vitalia Nikola led sales of weight management in 2010, accounting for a strong 19% value share. This company benefits from offering a wide range of weight management and from its wide distribution network. Vitalia was the leading player in weight loss supplements in 2010, with 20% value share. The company meanwhile ranked second in meal replacement slimming with 17% value share and second in slimming teas with 25% share in 2010.

PROSPECTS

  • Weight management is expected to benefit from a growing focus on weight during the forecast period. The government is increasingly recognising the cost of the country’s weight problems, due to associated health problems, and is thus likely to invest in consumer education campaigns during the forecast period. There is also expected to be a growing focus on weight in the country’s media. The country’s mainstream media is likely to cover issues such as rising childhood obesity while women’s lifestyle magazines, websites and TV programmes are set to increasingly focus on diet and exercise trends.

CATEGORY DATA

  • Table 80 Sales of Weight Management by Category: Value 2005-2010
  • Table 81 Sales of Weight Management by Category: % Value Growth 2005-2010
  • Table 82 Weight Management Company Shares 2006-2010
  • Table 83 Weight Management Brand Shares 2007-2010
  • Table 84 Forecast Sales of Weight Management by Category: Value 2010-2015
  • Table 85 Forecast Sales of Weight Management by Category: % Value Growth 2010-2015

Wound Care in Macedonia - Category Analysis

HEADLINES

TRENDS

  • Wound care benefited from widening distribution towards the end of the review period, with these products gaining an increasing distribution presence in supermarkets/hypermarkets and “other” grocery retailers. This trend was notably driven by players such as Hartmann and Seyitler Kimya, which greatly expanded distribution for their Dermaplast wasserfest waterproof plasters and Pelikan bandages respectively in 2010. Widening availability and affordable prices encouraged consumers to buy wound care in 2010.

COMPETITIVE LANDSCAPE

  • Shifts in share in wound care were largely linked to distribution presence at the end of the review period. Tosama remained the leading player in 2010, accounting for 17% value share thanks to its strong distribution via both supermarkets/hypermarkets and chemists/pharmacies. However, the company lost around two percentage points in value share, with this chiefly due to stronger competition in grocery retailers.

PROSPECTS

  • There is expected to be an ongoing shift to non-specialist distribution channels for wound care during the forecast period. Supermarkets/hypermarkets and “other” grocery retailers are expected to continue to gain share, with consumers increasingly picking these products up alongside their regular grocery shop. This will pose problems for domestic players with a strong focus on distribution via chemists/pharmacies, namely Alkaloid and Galafarm, with these players likely to lose share as a result.

CATEGORY DATA

  • Table 86 Sales of Wound Care by Category: Value 2005-2010
  • Table 87 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 88 Wound Care Company Shares 2006-2010
  • Table 89 Wound Care Brand Shares 2007-2010
  • Table 90 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 91 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Child-Specific Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Child-Specific Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Child-Specific Consumer Health
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
          • Child-Specific Cough, Cold and Allergy Remedies
            • Child-Specific Allergy Remedies
            • Child-Specific Cough/Cold Remedies
          • Child-Specific Digestive Remedies
            • Child-Specific Diarrhoeal Remedies
            • Child-Specific Indigestion and Heartburn Remedies
            • Child-Specific Laxatives
            • Child-Specific Motion Sickness Remedies
          • Child-Specific Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Child-Specific Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Analysis by type
      • Herbal/traditional vs standard
      • Pricing
      • Smoking population - number of adult smokers
      • Smoking prevalence - % of adult population

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices % growth
      • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices % growth
      • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices % growth
      • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices % growth
      • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      RELATED

      Consumer Lifestyle

      Future Demographic

      Country Report